BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parra-Herran C, Howitt BE. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features. Surg Pathol Clin 2019;12:363-96. [PMID: 31097109 DOI: 10.1016/j.path.2019.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Hinchcliff E, Lawson B, Fleming ND. Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00010-0] [Reference Citation Analysis]
2 Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, Haase H, Harter P, Hettmer S, Horn L, Juhasz-boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss H, Thiel F, Ulrich UA, Vogl T, Vordermark D, Wallwiener M, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021). Geburtshilfe Frauenheilkd 2022;82:1337-1367. [DOI: 10.1055/a-1897-5124] [Reference Citation Analysis]
3 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
4 Horn L, Hiller GGR, Mayr D, Schmoeckel E, Höhn AK. Praktisch-diagnostische Aspekte uteriner Leiomyosarkome im Kontext der WHO-Klassifikation 2020. Pathologe 2022;43:196-201. [DOI: 10.1007/s00292-022-01064-6] [Reference Citation Analysis]
5 Roy M, Musa F, Taylor SE, Huang M. Uterine Sarcomas: How to Navigate an Ever-Growing List of Subtypes. Am Soc Clin Oncol Educ Book 2022;42:1-10. [PMID: 35471831 DOI: 10.1200/EDBK_350955] [Reference Citation Analysis]
6 kumari P, kumari S, pankaj S, abhilashi K, rani J. IMT of Vulvovaginal Region: A Rare Case Report with Recurrence. J Obstet Gynecol India. [DOI: 10.1007/s13224-022-01637-8] [Reference Citation Analysis]
7 Purwar R, Soni K, Shukla M, Verma A, Kumar T, Pandey M. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review. World J Surg Oncol 2022;20:62. [PMID: 35232443 DOI: 10.1186/s12957-021-02462-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maccaroni E, Lunerti V, Agostinelli V, Giampieri R, Zepponi L, Pagliacci A, Berardi R. New Insights into Hormonal Therapies in Uterine Sarcomas. Cancers 2022;14:921. [DOI: 10.3390/cancers14040921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 张 艳. A Case of Uterine Inflammatory Myofibroblastic Tumor. ACM 2022;12:4978-4982. [DOI: 10.12677/acm.2022.126721] [Reference Citation Analysis]
10 Shafeghat M, Balibegloo M, Rezaei N. Interdisciplinary Approach in Genitourinary Cancers. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_72] [Reference Citation Analysis]
11 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
12 Aminimoghaddam S, Rahbari A, Pourali R. Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report. J Med Case Rep 2021;15:570. [PMID: 34838127 DOI: 10.1186/s13256-021-03172-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Le Page C, Almadani N, Turashvili G, Bataillon G, Portelance L, Provencher D, Mes-Masson AM, Gilks B, Hoang L, Rahimi K. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study. Int J Gynecol Pathol 2021;40:487-94. [PMID: 33720083 DOI: 10.1097/PGP.0000000000000730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Causa Andrieu P, Woo S, Kim TH, Kertowidjojo E, Hodgson A, Sun S. New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions. Curr Opin Oncol 2021;33:464-75. [PMID: 34172593 DOI: 10.1097/CCO.0000000000000758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang J, Yang Q, Zhang N, Wang D. Uterine angiomyolipoma: a clinical analysis of 8 cases and literature review. Arch Gynecol Obstet 2021;304:171-7. [PMID: 33569612 DOI: 10.1007/s00404-021-05992-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ayhan A, Tunc M, Boran N, Khatib G, Gokcu M, Simsek T, Ozen OI, Toptas T, Yalcin I, Meydanli MM. High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001. Arch Gynecol Obstet 2021;304:475-83. [PMID: 33392719 DOI: 10.1007/s00404-020-05915-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Cadena I, Chen A, Arvidson A, Fogg KC. Biomaterial strategies to replicate gynecological tissue. Biomater Sci 2021;9:1117-34. [DOI: 10.1039/d0bm01240h] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 Wei J, Purdy J. Uterine Mesenchymal Neoplasia. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_6] [Reference Citation Analysis]
19 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
20 Buza N, Euscher ED. Intraoperative Consultation. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_13] [Reference Citation Analysis]
21 Dai Y, Leng J. The Clinical Features and Diagnosis of Adenomyosis. Adenomyosis 2021. [DOI: 10.1007/978-981-33-4095-4_4] [Reference Citation Analysis]
22 Cabrera S, Bebia V, Acosta U, Franco-Camps S, Mañalich L, García-Jiménez A, Gil-Moreno A. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma. Clin Transl Oncol 2021;23:1210-9. [PMID: 33210235 DOI: 10.1007/s12094-020-02512-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM Jr, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Mod Pathol 2021;34:1008-16. [PMID: 33077922 DOI: 10.1038/s41379-020-00705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
24 Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer 2020;139:149-68. [PMID: 32992154 DOI: 10.1016/j.ejca.2020.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
25 Mindiola-Romero AE, Liu X, Dillon JL, Talarico M, Smith G, Zhang L, Linos K. Metastatic low-grade endometrial stromal sarcoma after 24 years: A case report and review of recent molecular genetics. Diagn Cytopathol 2021;49:E99-E105. [PMID: 32910526 DOI: 10.1002/dc.24601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Momeni-Boroujeni A, Chiang S. Uterine mesenchymal tumours: recent advances. Histopathology 2020;76:64-75. [PMID: 31846533 DOI: 10.1111/his.14008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
27 Mulchandani NJ, Vimala R. Uterine Angiomyolipoma: A Case Report and Review of Literature. Indian J Gynecol Oncolog 2020;18. [DOI: 10.1007/s40944-020-00426-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Han L, Liu YJ, Ricciotti RW, Mantilla JG. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review. Genes Chromosomes Cancer 2020;59:428-32. [PMID: 32237188 DOI: 10.1002/gcc.22845] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
29 Etlinger P, Kuthi L, Kovács T. Inflammatory Myofibroblastic Tumors in the Uterus: Childhood-Case Report and Review of the Literature. Front Pediatr 2020;8:36. [PMID: 32117841 DOI: 10.3389/fped.2020.00036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]